Francesco Bertoni Selected Research

5-(4-phenylbutoxy)psoralen

2/2021

Data describing the effects of potassium channels modulators on outward currents measured in human lymphoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Bertoni Research Topics

Disease

69	Neoplasms (Cancer) 04/2022 - 02/2005
50	Lymphoma (Lymphomas) 01/2022 - 04/2002
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 07/2005
12	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2020 - 11/2004
11	B-Cell Lymphoma (Lymphoma, B Cell) 10/2020 - 01/2007
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2007
7	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018 - 08/2011
6	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 04/2002
6	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2016
6	Leukemia 10/2020 - 10/2011
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2005
5	Multiple Myeloma 10/2019 - 01/2007
4	Genetic Translocation (Chromosomal Translocation) 11/2015 - 01/2006
3	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 10/2019
3	Ovarian Neoplasms (Ovarian Cancer) 06/2012 - 10/2006
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 01/2009
2	Thrombocytopenia (Thrombopenia) 12/2022 - 01/2022
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2008
2	T-Cell Lymphoma (Lymphoma, T Cell) 10/2020 - 03/2015
2	Trisomy (Trisomies) 07/2020 - 01/2018
2	Carcinogenesis 01/2018 - 04/2015
2	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2016 - 08/2012
2	Infections 02/2012 - 03/2005
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2010 - 07/2006
2	Uniparental Disomy 05/2008 - 07/2006
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Clinical Deterioration 01/2022
1	Neutropenia 01/2022
1	Hypertriglyceridemia 01/2022
1	Hyperphosphatemia 01/2022
1	Stomatitis 01/2022
1	Muscle Spasticity (Spastic) 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2008
13	Biological ProductsIBA 01/2022 - 01/2009
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2006
7	OTX015IBA 12/2019 - 04/2015
6	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2011
6	Phosphotransferases (Kinase)IBA 11/2021 - 04/2015
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2011
6	MicroRNAs (MicroRNA)IBA 11/2021 - 02/2007
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
5	Transcription Factors (Transcription Factor)IBA 04/2022 - 01/2006
5	Anaplastic Lymphoma KinaseIBA 01/2018 - 08/2011
5	NF-kappa B (NF-kB)IBA 01/2018 - 11/2004
5	AntigensIBA 03/2015 - 07/2005
5	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2012 - 05/2007
4	venetoclaxIBA 12/2022 - 06/2019
4	ChromatinIBA 04/2022 - 03/2015
4	Histone Deacetylase InhibitorsIBA 01/2021 - 03/2015
4	Rituximab (Mabthera)FDA Link 09/2016 - 02/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 03/2005
3	UbiquitinIBA 01/2021 - 12/2007
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 09/2016
3	Ligases (Synthetase)IBA 01/2021 - 12/2007
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
3	Agammaglobulinaemia Tyrosine KinaseIBA 12/2019 - 09/2016
3	ibrutinibIBA 01/2018 - 01/2016
3	Everolimus FDA Link 01/2017 - 07/2012
3	Doxycycline (Periostat)FDA LinkGeneric 01/2016 - 11/2011
3	Cyclin D1IBA 11/2015 - 01/2007
2	MethyltransferasesIBA 01/2022 - 01/2017
2	Protein Isoforms (Isoforms)IBA 11/2021 - 12/2007
2	TrabectedinIBA 12/2020 - 01/2019
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 01/2020
2	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 07/2020 - 01/2018
2	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 07/2020 - 01/2018
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2019 - 06/2019
2	Small Interfering RNA (siRNA)IBA 10/2019 - 12/2007
2	Proteasome InhibitorsIBA 10/2019 - 06/2012
2	TOR Serine-Threonine KinasesIBA 06/2019 - 07/2012
2	pixantrone (BBR 2778)IBA 01/2019 - 01/2018
2	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2018 - 01/2018
2	Circulating Tumor DNAIBA 01/2018 - 01/2018
2	EnzymesIBA 01/2017 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 10/2008
2	Formaldehyde (Formol)FDA Link 08/2012 - 10/2008
2	ParaffinIBA 08/2012 - 10/2008
2	fludarabineIBA 03/2012 - 12/2011
1	obinutuzumabIBA 12/2022
1	Enhancer RNAsIBA 04/2022
1	Decitabine FDA Link 01/2022
1	temsirolimus FDA Link 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2021
1	Immunomodulating AgentsIBA 11/2021
1	5-(4-phenylbutoxy)psoralenIBA 02/2021
1	TRAM 34IBA 02/2021
1	PotassiumIBA 02/2021
1	Riluzole FDA LinkGeneric 02/2021
1	Potassium Channels (Potassium Channel)IBA 02/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021

Therapy/Procedure

25	Therapeutics 12/2022 - 04/2002
4	Drug Therapy (Chemotherapy) 01/2020 - 11/2011
2	Radiotherapy 03/2014 - 11/2011
2	Time-to-Treatment 01/2012 - 01/2010
2	Organ Transplantation 05/2010 - 07/2006